Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23429703.
- Also identified by DOI 10.1126/science.1228792 and PMC identifier 3753690.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cellular growth signals stimulate anabolic processes. The mechanistic target of rapamycin complex 1 (mTORC1) is a protein kinase that senses growth signals to regulate anabolic growth and proliferation. Activation of mTORC1 led to the acute stimulation of metabolic flux through the de novo pyrimidine synthesis pathway. mTORC1 signaling posttranslationally regulated this metabolic pathway via its downstream target ribosomal protein S6 kinase 1 (S6K1), which directly phosphorylates S1859 on CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase), the enzyme that catalyzes the first three steps of de novo pyrimidine synthesis. Growth signaling through mTORC1 thus stimulates the production of new nucleotides to accommodate an increase in RNA and DNA synthesis needed for ribosome biogenesis and anabolic growth.
Medical subject headings
- Aspartate Carbamoyltransferase
- Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)
- Dihydroorotase
- Multiprotein Complexes
- Pyrimidines
- Ribosomal Protein S6 Kinases
- TOR Serine-Threonine Kinases